Czechia vs Switzerland: The number of people with susceptibility test result for rifampicin
Czechia
239
in 2021
Switzerland
220
in 2021
Czechia rank
90th
Switzerland rank
92nd
The number of people with susceptibility test result for rifampicin over time
- Czechia
- Switzerland
How they compare
Czechia currently reports 239 against 220 in Switzerland, a difference of 19.
That makes Czechia's figure about 1.1 times Switzerland's.
Across all 5 years both countries report, Czechia has been ahead every year.
Czechia ranks 90th and Switzerland ranks 92nd of 155 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 294 | 240.33 | 53.67 | Czechia |
| 2020s | 231 | 195.5 | 35.5 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or Switzerland?
- Czechia, at 239 against 220 in Switzerland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and Switzerland?
- 19, with Czechia ahead.
- How many years of comparable data are there for Czechia and Switzerland?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and Switzerland rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 90th and Switzerland ranks 92nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.